PURPOSE: The purpose of this article is to evaluate the contributions of diabetic complications to depression beyond the contributions of demographic characteristics in patients with type 2 diabetes. Further, this article evaluates the contributions of diabetic complications, depression, and quality of life to A1C (also know as HbA1c) beyond the contributions of demographic characteristics in individuals with type 2 diabetes. DATA SOURCES: A cross-sectional survey of 55 individuals with type 2 diabetes attending an inner city diabetes specialty clinic. Patients completed the Beck Depression Inventory - II, the Inventory of Depressive Symptomatology Self-Report, the Medical Outcome Study Short Form-36, and a demographic questionnaire. A1C and diabetes-related comorbidities were obtained from the patients' medical records. CONCLUSIONS: Being younger and female were associated with depression in individuals with type 2 diabetes. After controlling for age and gender, neuropathy tended to add to the prediction of depression; other comorbidities did not. Being black was associated with poor diabetic control (A1C > 7). After controlling for race, neuropathy and retinopathy predicted poor diabetes control and depression tended to predict poor diabetes control. IMPLICATIONS FOR PRACTICE: Given the high prevalence of depression, the relationship of depression with poor diabetic self-care and medication adherence, and the increased cost of treatment for patients with depression among individuals with type 2 diabetes, assessment of depression is crucial. Further research is needed to establish effective treatment of depression and its effect on glycemic control in patients with type 2 diabetes.
PURPOSE: The purpose of this article is to evaluate the contributions of diabetic complications to depression beyond the contributions of demographic characteristics in patients with type 2 diabetes. Further, this article evaluates the contributions of diabetic complications, depression, and quality of life to A1C (also know as HbA1c) beyond the contributions of demographic characteristics in individuals with type 2 diabetes. DATA SOURCES: A cross-sectional survey of 55 individuals with type 2 diabetes attending an inner city diabetes specialty clinic. Patients completed the Beck Depression Inventory - II, the Inventory of Depressive Symptomatology Self-Report, the Medical Outcome Study Short Form-36, and a demographic questionnaire. A1C and diabetes-related comorbidities were obtained from the patients' medical records. CONCLUSIONS: Being younger and female were associated with depression in individuals with type 2 diabetes. After controlling for age and gender, neuropathy tended to add to the prediction of depression; other comorbidities did not. Being black was associated with poor diabetic control (A1C > 7). After controlling for race, neuropathy and retinopathy predicted poor diabetes control and depression tended to predict poor diabetes control. IMPLICATIONS FOR PRACTICE: Given the high prevalence of depression, the relationship of depression with poor diabetic self-care and medication adherence, and the increased cost of treatment for patients with depression among individuals with type 2 diabetes, assessment of depression is crucial. Further research is needed to establish effective treatment of depression and its effect on glycemic control in patients with type 2 diabetes.
Authors: Kristin L Schneider; Emily Panza; Barbara Handschin; Yunsheng Ma; Andrew M Busch; Molly E Waring; Bradley M Appelhans; Matthew C Whited; Jacey Keeney; Daniel Kern; Mihaela Blendea; Ira Ockene; Sherry L Pagoto Journal: Behav Ther Date: 2015-10-31
Authors: Krystal Khoo; Ryan E K Man; Gwyn Rees; Preeti Gupta; Ecosse L Lamoureux; Eva K Fenwick Journal: Qual Life Res Date: 2019-03-16 Impact factor: 4.147
Authors: Cf Frederick Otieno; Joseph E Kanu; Emma M Karari; Violet Okech-Helu; Mark D Joshi; Kenn Mutai Journal: Diabetes Metab Syndr Obes Date: 2017-04-28 Impact factor: 3.168
Authors: Nitin Joseph; Bhaskaran Unnikrishnan; Y P Raghavendra Babu; M Shashidhar Kotian; Maria Nelliyanil Journal: Indian J Endocrinol Metab Date: 2013-07
Authors: Maria Donald; Jo Dower; Joseph R Coll; Peter Baker; Bryan Mukandi; Suhail A R Doi Journal: Health Qual Life Outcomes Date: 2013-10-16 Impact factor: 3.186
Authors: Jessie N Zurita-Cruz; Leticia Manuel-Apolinar; María Luisa Arellano-Flores; Alejandro Gutierrez-Gonzalez; Alma Gloria Najera-Ahumada; Nelly Cisneros-González Journal: Health Qual Life Outcomes Date: 2018-05-15 Impact factor: 3.186